Your browser doesn't support javascript.
loading
Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis.
Dejoies, Loren; Boukthir, Sarrah; Péan de Ponfilly, Gauthier; Le Guen, Ronan; Zouari, Asma; Potrel, Sophie; Collet, Anaïs; Auger, Gabriel; Jacquier, Hervé; Fihman, Vincent; Dortet, Laurent; Cattoir, Vincent.
Afiliação
  • Dejoies L; CHU de Rennes, Service de Bactériologie et Hygiène Hospitalière, Rennes, France.
  • Boukthir S; U1230 'ARN régulateurs Bactériens et Médecine', Université Rennes 1, Rennes, France.
  • Péan de Ponfilly G; CHU de Rennes, Service de Bactériologie et Hygiène Hospitalière, Rennes, France.
  • Le Guen R; Hôpital Lariboisière, Service de Bactériologie-Virologie, Paris, France.
  • Zouari A; Hôpitaux Universitaires Henri Mondor, Unité de Bactériologie-Hygiène, Créteil, France.
  • Potrel S; CHU de Rennes, Service de Bactériologie et Hygiène Hospitalière, Rennes, France.
  • Collet A; CNR de la Résistance aux Antibiotiques (laboratoire associé 'Entérocoques'), Rennes, France.
  • Auger G; CHU de Rennes, Service de Bactériologie et Hygiène Hospitalière, Rennes, France.
  • Jacquier H; CNR de la Résistance aux Antibiotiques (laboratoire associé 'Entérocoques'), Rennes, France.
  • Fihman V; CHU de Rennes, Service de Bactériologie et Hygiène Hospitalière, Rennes, France.
  • Dortet L; CNR de la Résistance aux Antibiotiques (laboratoire associé 'Entérocoques'), Rennes, France.
  • Cattoir V; CHU de Rennes, Service de Bactériologie et Hygiène Hospitalière, Rennes, France.
J Antimicrob Chemother ; 75(9): 2587-2593, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32449911
ABSTRACT

BACKGROUND:

Linezolid-resistant enterococci (LRE) causing infections that are challenging to treat are rising, highlighting the need for reliable screening of LRE clinical isolates.

OBJECTIVES:

To evaluate the ability of the broth microdilution (BMD) method for LRE detection and to assess the performance of seven commercially available techniques for linezolid susceptibility testing.

METHODS:

A collection of 100 clinical isolates (80 Enterococcus faecium and 20 Enterococcus faecalis), including 20 optrA-positive isolates, 17 poxtA-positive isolates and 1 optrA/poxtA-positive E. faecium isolate, were studied. MICs were determined after 18 h [Day 1 (D1)] and 42 h [Day 2 (D2)] of incubation and interpreted following EUCAST and CLSI guidelines, which currently provide different interpretative breakpoints. Performance of commercial techniques was compared with BMD results.

RESULTS:

MIC50/D1 and MIC50/D2 were both 8 mg/L, while MIC90/D1 and MIC90/D2 were 16 and 32 mg/L, respectively. MICD1 values for poxtA-positive isolates were lower than those for optrA-positive isolates. Proportions of susceptible isolates at D1 and D2 were 48% and 41%, respectively, according to EUCAST breakpoints and 35% and 13%, respectively, according to CLSI criteria (the proportions of isolates categorized as intermediate following CLSI recommendations were 13% and 28% at D1 and D2, respectively). Percentage susceptibility assessed by the commercially available techniques was always higher. The four commercial methods allowing MIC determination provided an overall essential agreement of ≥90% at D1. Categorical agreement and error rates were generally improved at D2.

CONCLUSIONS:

Non-automated methods (Sensititre and UMIC) and, to a lesser extent, gradient strip Etest appear to show an acceptable correlation with the BMD reference method for the detection of isolates with low MICs of linezolid after prolonged incubation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Enterococcus faecium Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Enterococcus faecium Idioma: En Ano de publicação: 2020 Tipo de documento: Article